Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during 177Lu/225Ac treatment in neuroendocrine tumors and metastatic prostate cancer.
Dadgar H, Pashazadeh A, Norouzbeigi N, Assadi M, Al-Balooshi B, Baum RP, Al-Ibraheem A, Haidar M, Beheshti M, Geramifar P, Vali R, Mohammadi S, Dash S, Malasani V, Cimini A, Ricci M, Esmail AA, Murad S, Marafi F, Treglia G, Khalaf AN, Anwar FM, Usmani S, Omar Y, Muhsin H, Tyurin IE, Zakhary A, Al-Sebaie S, Cortes DM, AlHashim M, Arabi H, Zaidi H.
Dadgar H, et al. Among authors: arabi h.
Theranostics. 2025 Mar 18;15(10):4368-4397. doi: 10.7150/thno.107963. eCollection 2025.
Theranostics. 2025.
PMID: 40225563
Free PMC article.
Review.